# Reference table of clinically meaningful age bins 

| Population / Application                    | Age Bins                                                                                                                                                | Rationale / Notes                                                                                                       |
| ------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------- | ----------------------------------------------------------------------------------------------------------------------- |
| **Neonatal & Pediatric**                    | 0–27 days (neonate) <br> 28–364 days (infant) <br> 1–2 years (toddler) <br> 3–5 years (preschool) <br> 6–12 years (child) <br> 13–17 years (adolescent) | Rapid physiological changes, drug metabolism, growth patterns; aligns with pediatric guidelines.                        |
| **Adult Preventive / Screening**            | 18–29, 30–39, 40–49, 50–59, 60–69, 70–79, 80+                                                                                                           | Matches guideline thresholds for screenings (e.g., colonoscopy, mammography); 10-year bins are common for epidemiology. |
| **Cardiovascular Risk / Metabolic Studies** | 18–34 (young adult) <br> 35–49 (early middle age) <br> 50–64 (late middle age) <br> 65–74 (early elderly) <br> 75+ (late elderly)                       | Reflects age-related changes in cardiovascular and metabolic risk.                                                      |
| **Geriatrics / Frailty**                    | 60–69, 70–79, 80–89, 90+                                                                                                                                | Multimorbidity, functional decline, polypharmacy; wider bins for advanced age due to smaller numbers.                   |
| **Pharmacology / Drug Dosing**              | <1y (infant) <br> 1–12y (child) <br> 13–17y (adolescent) <br> 18–64y (adult) <br> 65+ (elderly)                                                         | Focuses on pharmacokinetics and pharmacodynamics differences.                                                           |
| **Immunization / Vaccine Studies**          | 0–5y (child) <br> 6–17y (adolescent) <br> 18–49y (adult) <br> 50–64y (older adult) <br> 65+ (elderly)                                                   | Aligns with CDC and WHO vaccination recommendations.                                                                    |
| **Cancer Screening / Oncology**             | 40–49, 50–59, 60–69, 70–79, 80+                                                                                                                         | Matches screening guideline cutoffs for mammography, colonoscopy, prostate cancer.                                      |
| **Population Health / EHR Analytics**       | Quartiles or deciles of age distribution                                                                                                                | Useful for statistical modeling; ensures roughly equal sample sizes per bin.                                            |
| **Rare Pediatric Conditions**               | Month-level bins for <1y, year-level bins for 1–12y                                                                                                     | Needed when incidence is high in the first months of life.                                                              |
